 |
|
Pro. Alexander Eggermont,
Director, Institute Gustave Roussy, France |
 |
|
Dr. Yan Sun,
Member of Chinese Academy of Sciences, Director, National GCP Center for Anticancer Agents, Cancer Hospital/Institute, CAMS & PUMC, China |
| |
|
|
|
|
|
 |
|
Dr. Bruno Osterwalder,
Senior VP, Senior Strategic Advisor Oncology, Global Head Early Clinical Development Oncology, Merck Serono, Switzerland |
 |
|
Dr. Xin-Yuan Liu,
Member of Chinese Academy of Sciences, Institute of Biochemistry and Cell Biology, Professor, College of Life Science, Zhejiang Sci-Tech University, China |
| |
|
|
|
|
|
 |
|
Dr. Danny N. Dhanasekaran,
Professor, University of Oklahoma Health Sciences Center, USA |
 |
|
Dr. Cheng-Wen Wu,
Distinguished Chair, Professor, National Yang-Ming University, Taiwan |
| |
|
|
|
|
|
 |
|
Dr. Juergen Engel,
President & CEO, AEterna Zentaris Inc., Canada |
 |
|
Dr. Rupert C. Ecker,
CEO, TissueGnostics GmbH, Austria |
| |
|
|
|
|
|
 |
|
Dr. Alvaro Macieira-Coelho,
Director of Research, National Institute of Health and Medical Research (INSERM), France |
 |
|
Dr. Yuan-Soon Ho,
Professor, Chairman, Translational Cancer Research Center, Graduate Institute of Biomedical Technology, Taipei Medical University, Taiwan |
| |
|
|
|
|
|
 |
|
Dr. Raymond Bergan,
Professor, Director of Experimental Therapeutics, Robert H. Lurie Cancer Center of Northwestern University, USA |
 |
|
Dr. Yves Jean Bignon,
Professor and Director, Department of Oncogenetics, Jean Perrin Center, France |